More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Press Releases
    • Media Coverage
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Press Releases
    • Media Coverage

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point

by Kyle Porter | Jan 24, 2023 | HempMeds Brasil, Press Releases

New Products Offer 3,000mg to 6,000mg, Will Come in Jars of 30 and 60mL, Presenting Significant Cost Savings to Rapidly Growing Brazil Market SAN DIEGO, CA – January 23, 2023 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded...

Medical Marijuana, Inc. Subsidiary HM Pharma Submits CBD Product Dossier; Receives Sanitary Registration in Brazil

by Kyle Porter | Aug 11, 2022 | HempMeds Brasil, Media Coverage, Press Releases

SAN DIEGO, CA, Aug. 11, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical...

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Exponential Growth; Receives Validation From Medical Community

by Kyle Porter | Apr 21, 2022 | HempMeds Brasil, Press Releases

SAN DIEGO, CA, April 21, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived...

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Sponsors First Brazilian Obesity Medicine Symposium

by Kyle Porter | Feb 24, 2022 | HempMeds Brasil, Press Releases

SAN DIEGO, CA, Feb. 24, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical...

Medical Marijuana, Inc. Subsidiary HempMeds® Welcomes UFC Champion Raoni Barcelos as Brand Spokesperson

by Kyle Porter | Jun 24, 2021 | HempMeds Brasil, Press Releases

SAN DIEGO, June 24, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived...

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces April 2021 as the Best Revenue Month in Company History

by Kyle Porter | May 11, 2021 | HempMeds Brasil, Press Releases

SAN DIEGO, CA, May 11, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical...
« Older Entries

POPULAR

  • HempMeds®, Subsidiary of Medical Marijuana, Inc., Expands Popular CBD Oil Tincture Line with Two New Flavors
  • Medical Marijuana Inc.’s Canipa Holdings Drive Dixie X and CanChew Gum Toward EU Marketing Approval And Clinical Development CanChew Canipa Holdings Dixie Botanicals
  • HempMeds® and CBD Receive Major News Coverage in Pittsburgh Dixie Botanicals Hempmeds Real Scientific Hemp Oil
  • Medical Marijuana, Inc. Announces First Quarter 2012 Results Dixie Botanicals
  • Medical Marijuana, Inc. Subsidiary Dixie Botanicals™ Appoints New Director of Sales and Marketing Brent Albin Dixie Botanicals

LAST NEWS

  • Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Announces New Fruit-Flavored Energy Kicks
  • Medical Marijuana, Inc. Subsidiary Kannaway® Announces Positive Preliminary Results of Validcare Clinical Study on CBD Liver Toxicity
  • Medical Marijuana, Inc. Subsidiary Kannaway® Celebrates Best Revenue Month in Company History for South Africa Division in March 2022
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary Dixie Botanicals™ Appoints New Director of Sales and Marketing Brent Albin

Subscribe for Company Updates

* indicates required

Follow us on

social networks

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.